Bleichroeder LP’s NeuroOne Medical Technologies NMTC Stock Holding History

Bleichroeder LP’s Portfolio NMTC Stock Details NMTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.03M	Sell	666,666 -1	-0%	-$4	0.36%	34
2026 Q1	$3.11M	Hold	666,667	–	–	0.54%	25
2025 Q4	$3.03M	Hold	666,667	–	–	0.53%	24
2025 Q3	$3.55M	Hold	666,667	–	–	0.69%	20
2025 Q2	$2.71M	Buy	+666,667	New	+$2.46M	0.67%	18
2022 Q1	–	Sell	-62,500	Closed	-$728K	–	115
2021 Q4	$728K	Buy	+62,500	New	+$1.01M	0.11%	56

Other funds holding NMTC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bleichroeder LP's NMTC Position: Q2 2026 in Review

Bleichroeder LP reduced its NeuroOne Medical Technologies (NMTC) stake by 0% in Q2 2026, selling an estimated $4 and leaving 666,666 shares worth $2.03M. The position accounts for 0.36% of the portfolio, ranked #34.

Bleichroeder LP first reported a position in NMTC in Q4 2021 and has held it in 6 quarters since. The position peaked at $3.55M in Q3 2025. 26 funds tracked by Wall St. Rank hold NMTC as of Q2 2026.

Bleichroeder LP held 666,666 shares of NeuroOne Medical Technologies worth $2.03M as of Q2 2026.
Bleichroeder LP sold 1 NeuroOne Medical Technologies share in Q2 2026, an estimated $4.
NeuroOne Medical Technologies made up 0.36% of Bleichroeder LP's portfolio in Q2 2026, its #34 holding.
Bleichroeder LP first reported a position in NeuroOne Medical Technologies in Q4 2021 and has held it in 6 quarters since.
Bleichroeder LP's NeuroOne Medical Technologies position peaked at $3.55M in Q3 2025.
26 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q2 2026.

Based on Bleichroeder LP's 13F filing for Q2 2026, filed 13 Aug 2026.